Patrick Lin
Co-Founder, Chief Business & Strategy OfficerMr. Patrick Lin Co-Founded Processa Pharmaceuticals, Inc. (formerly Promet Therapeutics, LLC) in 2017. He serves as Chief Business & Strategy Officer at Processa Pharmaceuticals, Inc. since October 4, 2017 and served as its Director since October 2017 until November 3, 2020. He is the Founder of Heatwurx, Inc. and serves as its Chief Business & Strategy Officer. Mr. Lin has been the Chief Investment Officer and Portfolio Manager of Primarius Capital LLC since 2002. Mr. Lin serves as Business Advisor at LifeScience PLUS, Inc. For more than past several years, he was Managing Partner of Primarius Capital. Mr. Lin has financing and investing experience in the Biopharm Sector. For several years prior to forming Primarius Capital, Mr. Lin worked at several Wall Street banking and brokerage firms including Robertson Stephens & Co., E*Offering and Goldman Sachs & Co. Mr. Lin was a Co-Founding Partner of E*Offering, the investment bank of E*Trade, served as Managing Director of Equity Capital Markets. He was the Chairman of Processa Pharmaceuticals, Inc. Mr. Lin was a Principal in Institutional Research Sales at Robertson Stephens & Co. He has been Internal Director of Heatwurx, Inc. since October 04, 2017. Mr. Lin serves as a Member of Advisory Board at LifeScience PLUS, Inc. Mr. Lin received an MBA from Kellogg Graduate School of Management, an M.S. in Engineering Management and a BS from the University of Southern California.
Positions
- Company NameProcessa Pharmaceuticals, Inc.Stock CodePCSAPositionCo-Founder, Chief Business & Strategy Officer
